vs

Side-by-side financial comparison of Bumble Inc. (BMBL) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

Bumble Inc. is the larger business by last-quarter revenue ($224.2M vs $207.3M, roughly 1.1× Ultragenyx Pharmaceutical Inc.). Ultragenyx Pharmaceutical Inc. runs the higher net margin — -62.0% vs -218.7%, a 156.6% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs -14.3%). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs -8.5%).

Bumble is a mobile app for online dating and social networking. It was founded by Whitney Wolfe Herd and was launched in December 2014. Bumble is operated by Bumble Inc., which also owns Badoo.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

BMBL vs RARE — Head-to-Head

Bigger by revenue
BMBL
BMBL
1.1× larger
BMBL
$224.2M
$207.3M
RARE
Growing faster (revenue YoY)
RARE
RARE
+40.2% gap
RARE
25.9%
-14.3%
BMBL
Higher net margin
RARE
RARE
156.6% more per $
RARE
-62.0%
-218.7%
BMBL
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
-8.5%
BMBL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BMBL
BMBL
RARE
RARE
Revenue
$224.2M
$207.3M
Net Profit
$-490.2M
$-128.6M
Gross Margin
71.2%
Operating Margin
-256.8%
-54.7%
Net Margin
-218.7%
-62.0%
Revenue YoY
-14.3%
25.9%
Net Profit YoY
-11829.5%
3.5%
EPS (diluted)
$-3.96
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMBL
BMBL
RARE
RARE
Q4 25
$224.2M
$207.3M
Q3 25
$246.2M
$159.9M
Q2 25
$248.2M
$166.5M
Q1 25
$247.1M
$139.3M
Q4 24
$261.6M
$164.6M
Q3 24
$273.6M
$139.5M
Q2 24
$268.6M
$147.0M
Q1 24
$267.8M
$108.8M
Net Profit
BMBL
BMBL
RARE
RARE
Q4 25
$-490.2M
$-128.6M
Q3 25
$37.3M
$-180.4M
Q2 25
$-253.7M
$-115.0M
Q1 25
$13.4M
$-151.1M
Q4 24
$4.2M
$-133.2M
Q3 24
$-613.2M
$-133.5M
Q2 24
$27.4M
$-131.6M
Q1 24
$24.6M
$-170.7M
Gross Margin
BMBL
BMBL
RARE
RARE
Q4 25
71.2%
Q3 25
71.9%
Q2 25
70.1%
Q1 25
70.3%
Q4 24
Q3 24
Q2 24
Q1 24
99.1%
Operating Margin
BMBL
BMBL
RARE
RARE
Q4 25
-256.8%
-54.7%
Q3 25
25.9%
-106.9%
Q2 25
-136.3%
-64.8%
Q1 25
18.1%
-102.6%
Q4 24
14.1%
-74.3%
Q3 24
-306.3%
-94.6%
Q2 24
19.3%
-79.1%
Q1 24
18.2%
-151.9%
Net Margin
BMBL
BMBL
RARE
RARE
Q4 25
-218.7%
-62.0%
Q3 25
15.2%
-112.8%
Q2 25
-102.2%
-69.0%
Q1 25
5.4%
-108.5%
Q4 24
1.6%
-80.9%
Q3 24
-224.1%
-95.7%
Q2 24
10.2%
-89.5%
Q1 24
9.2%
-156.8%
EPS (diluted)
BMBL
BMBL
RARE
RARE
Q4 25
$-3.96
$-1.28
Q3 25
$0.33
$-1.81
Q2 25
$-2.45
$-1.17
Q1 25
$0.13
$-1.57
Q4 24
$0.09
$-1.34
Q3 24
$-5.11
$-1.40
Q2 24
$0.22
$-1.52
Q1 24
$0.19
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMBL
BMBL
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$175.8M
$421.0M
Total DebtLower is stronger
$590.6M
Stockholders' EquityBook value
$570.0M
$-80.0M
Total Assets
$1.4B
$1.5B
Debt / EquityLower = less leverage
1.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMBL
BMBL
RARE
RARE
Q4 25
$175.8M
$421.0M
Q3 25
$307.9M
$202.5M
Q2 25
$261.7M
$176.3M
Q1 25
$202.2M
$127.1M
Q4 24
$204.3M
$174.0M
Q3 24
$252.1M
$150.6M
Q2 24
$286.7M
$480.7M
Q1 24
$262.7M
$112.3M
Total Debt
BMBL
BMBL
RARE
RARE
Q4 25
$590.6M
Q3 25
Q2 25
Q1 25
Q4 24
$621.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BMBL
BMBL
RARE
RARE
Q4 25
$570.0M
$-80.0M
Q3 25
$675.5M
$9.2M
Q2 25
$577.6M
$151.3M
Q1 25
$814.5M
$144.2M
Q4 24
$824.5M
$255.0M
Q3 24
$852.6M
$346.8M
Q2 24
$1.7B
$432.4M
Q1 24
$1.6B
$140.3M
Total Assets
BMBL
BMBL
RARE
RARE
Q4 25
$1.4B
$1.5B
Q3 25
$2.2B
$1.2B
Q2 25
$2.2B
$1.3B
Q1 25
$2.5B
$1.3B
Q4 24
$2.5B
$1.5B
Q3 24
$2.6B
$1.5B
Q2 24
$3.5B
$1.6B
Q1 24
$3.5B
$1.3B
Debt / Equity
BMBL
BMBL
RARE
RARE
Q4 25
1.04×
Q3 25
Q2 25
Q1 25
Q4 24
0.75×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMBL
BMBL
RARE
RARE
Operating Cash FlowLast quarter
$59.1M
$-99.8M
Free Cash FlowOCF − Capex
$-100.8M
FCF MarginFCF / Revenue
-48.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMBL
BMBL
RARE
RARE
Q4 25
$59.1M
$-99.8M
Q3 25
$76.8M
$-91.4M
Q2 25
$71.2M
$-108.3M
Q1 25
$43.2M
$-166.5M
Q4 24
$-5.4M
$-79.3M
Q3 24
$93.5M
$-67.0M
Q2 24
$32.9M
$-77.0M
Q1 24
$2.4M
$-190.7M
Free Cash Flow
BMBL
BMBL
RARE
RARE
Q4 25
$-100.8M
Q3 25
$-92.7M
Q2 25
$-110.7M
Q1 25
$-167.8M
Q4 24
$-79.5M
Q3 24
$-68.6M
Q2 24
$-79.0M
Q1 24
$-193.9M
FCF Margin
BMBL
BMBL
RARE
RARE
Q4 25
-48.6%
Q3 25
-58.0%
Q2 25
-66.5%
Q1 25
-120.5%
Q4 24
-48.3%
Q3 24
-49.2%
Q2 24
-53.7%
Q1 24
-178.2%
Capex Intensity
BMBL
BMBL
RARE
RARE
Q4 25
0.5%
Q3 25
0.8%
Q2 25
1.5%
Q1 25
1.0%
Q4 24
0.1%
Q3 24
1.2%
Q2 24
1.4%
Q1 24
3.0%
Cash Conversion
BMBL
BMBL
RARE
RARE
Q4 25
Q3 25
2.06×
Q2 25
Q1 25
3.22×
Q4 24
-1.29×
Q3 24
Q2 24
1.20×
Q1 24
0.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMBL
BMBL

Bumble App$181.0M81%
Badoo App And Other$43.2M19%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons